Unique ID issued by UMIN | UMIN000010568 |
---|---|
Receipt number | R000011895 |
Scientific Title | Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients |
Date of disclosure of the study information | 2013/04/23 |
Last modified on | 2016/10/25 10:58:02 |
Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients
Postoperative QOL and body weight loss with perioperative Prosure administration for gastric cancer patients
Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients
Postoperative QOL and body weight loss with perioperative Prosure administration for gastric cancer patients
Japan |
gastric cancer
Gastrointestinal surgery |
Malignancy
NO
The aim of this study is to evaluate the degree of postoperative body weight loss and quality of life by the administration of Prosure for curatively resectable gastric cancer patients.
Efficacy
Phase II,III
Body weight loss and QOL score at 1/2/3/6 months after surgery
postoperative functional disorder, lean body mass and skeletal muscle volume at 1/2/3/6 months after surgery, relative performance of Prosure, incidence of surgical morbidity.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
4
Treatment
Medicine | Food |
Oral supplimentation of 2 packs of Prosure per day for 7 days before surgery and 20 days after surgery.
Oral supplimentation of 1 pack of Prosure and 1 can of Ensure Liquid per day for 7 days before surgery and 20 days after surgery.
Oral supplimentation of 2 cans of Ensure Liquid per day for 7 days before surgery and 20 days after surgery.
No nutritional supplimentation given perioperatively.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. curative resection is possible by total gastrectomy or distal gastrectomy
2. not treated preoperative chemotherapy
3. age: 20-80 years
4. ECOG performance status: 0-1
5. sufficient organ functions
6. written informed consent
1. reduced oral intake
2. Treated with icosapentate ethyl
3. supplements containing eicosapentaenoic acid
4. synchronous or metachronous cancer
5. lactate intolerance or allergic reaction to milk/soy
6. hemorrhagic tendency
7. uncontrolled diabetes mellitus
8. Systemic treatment with corticosteroids
9. unstable angina or cardiac infarction within 6 months
10. pulmonary disease under oxygenation
11. Woman with ongoing pregnancy or breast-feeding, or contemplating pregnancy
160
1st name | |
Middle name | |
Last name | Kentaro Kurashina |
Jichi Medical University Hospital
Department of Surgery
3311-1, Yakushiji, Shimotsuke city, Tochigi, 329-0498, Japan
0285-58-7371
kurashonan@jichi.ac.jp
1st name | |
Middle name | |
Last name | Kentaro Kurashina |
Jichi Medical University Hospital
Department of Surgery
3311-1, Yakushiji, Shimotsuke city, Tochigi, 329-0498, Japan
0285-58-7371
kurashonan@jichi.ac.jp
Jichi Medical University Hospital
Jichi Medical University
Self funding
Abbott Japan
NO
2013 | Year | 04 | Month | 23 | Day |
Unpublished
No longer recruiting
2013 | Year | 01 | Month | 29 | Day |
2013 | Year | 04 | Month | 23 | Day |
2014 | Year | 12 | Month | 31 | Day |
2013 | Year | 04 | Month | 23 | Day |
2016 | Year | 10 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011895